Health Tech 50 is the most up to date, comprehensive and insightful Global Health Tech VC ranking for the digital health community.

The Health Tech 50 ranking methodology was created by Kilo Health and Galen Growth. We sought to craft a methodology that would incorporate metrics that define a great investor. We reached beyond traditional financial performance metrics, taking into account less traditional metrics such as the portfolio companies’ maturity score, and partnership score to reflect interconnectedness and collaborative potential of the companies in the portfolio with external entities.

In the Health Tech 50 ranking, Venture Capital investors are ranked based on 5 distinct metrics. We have split the metrics into two separate groups: direct and indirect metrics.

Direct metrics:
These metrics take into account the investment activity of the investor. We only included investments into technology-enabled healthcare products and services that contribute to people‘s wellbeing, quality of lives, improve healthcare delivery, and speed up the transformation of the traditional healthcare sector. Investments into pharmaceutical, biotechnology and related innovations are not included into Health Tech 50 ranking.

There are three direct investor metrics used in our methodology. Each metric was taken into account while calculating the overall Investor Score. Each direct metric has its own weighting. All three direct metrics combined represent 45% of the final Investor Score.

Three direct metrics are as follows:
Metric #1: Companies invested in years 2022, 2023 and 2024 (Post-Covid19): number of investments into new health tech companies over the years 2022, 2023 and 2024 (2022.01 - 2024.06).
Metric #2: Exits (years 2022, 2023 and 2024 (Post-Covid19)): number of exits (health tech companies only) completed by the investor over the years 2022, 2023 and 2024 (2022.01 - 2024.06).
Metric #3: Portfolio companies (with a valuation above $100M): number of health tech companies in the portfolio valued above $100M (as of 2024.06).
Indirect metrics:
Indirect metrics take into account the non-investment related activity of the investor. Two indirect investor metrics were taken into account while calculating the overall Investor Score. Each indirect metric has its own weighting. Both indirect metrics combined represent 55% of the final Investor Score.

Two indirect metrics are as follows:
Metric #4: Alpha score: an average investor / fund portfolio maturity score.
Metric #5: Partnership score: reflects interconnectedness and collaborative potential of the companies in the portfolio with external entities, indicating the overall network influence and potential growth opportunities.

To be included in the list, investors have to have minimum 3 new investments during the period after-Covid19 (2022.01 - 2024.06).

The final Investor Score is derived based on 5 distinct metrics, and investors are ranked accordingly in the final Health Tech 50 list.

The final Health Tech 50 list will be published on the 5th of December, 2024.